Article Figures & Data
Figures
- Figure 1.
Visual Gains and Central Foveal Thickness During Open-Label Extension
BCVA, best corrected visual acuity; CFT, central foveal thickness; ETDRS, Early Treatment Diabetic Retinopathy Study.
Reproduced with permission from CC Wykoff, MD, PhD.
Tables
Tools
Open-Label Extension of RIDE and RISE Shows Improved Visual Outcomes Maintained without Ranibizumab Retreatment
Permalink:
Table of contents
Cited By...
- No citing articles found.